Company Filing History:
Years Active: 2004-2009
Title: Alexander Weisman: Innovator in Pharmaceutical Chemistry
Introduction
Alexander Weisman is a notable inventor based in Kiryat-Ekron, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for synthesizing important compounds. With a total of 3 patents to his name, Weisman continues to push the boundaries of innovation in his field.
Latest Patents
Weisman’s latest patents include groundbreaking work on the preparation of rocuronium bromide and its intermediates. One of his notable inventions is a novel process for preparing (2β,3α,5α,16β,17β)-17-acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl) androstane, which is a key intermediate in the synthesis of the skeletal muscle relaxant rocuronium bromide. Additionally, he has developed various crystalline forms of halobetasol propionate, characterized by specific power X-ray diffraction peak positions and intensities, which are detailed in his patent documentation.
Career Highlights
Weisman is currently associated with Chemagis Ltd., where he applies his expertise in pharmaceutical development. His work has not only advanced the field but has also contributed to the creation of effective therapeutic agents.
Collaborations
Throughout his career, Weisman has collaborated with talented individuals such as Joseph Kaspi and Itai Adin. These partnerships have fostered an environment of innovation and creativity, leading to the successful development of new pharmaceutical processes.
Conclusion
Alexander Weisman stands out as a prominent figure in pharmaceutical innovation, with a focus on synthesizing critical compounds. His contributions continue to impact the industry positively, showcasing the importance of research and development in healthcare.